---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-031482"
form_type: "8-K"
ticker: "RXST"
cik: "0001111485"
company_name: "RxSight, Inc."
filed_at: "2023-07-05T23:59:59+00:00"
generated_at: "2026-06-13T12:31:09.096899+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# RxSight refinances debt: $20M new loan at lower rate, extends maturity to 2028

## Summary
- Sold 834,748 common shares via ATM for $19.4M net proceeds; used $20M to repay existing debt.
- New $20M loan from Oxford Finance at floating rate ~11.5% vs prior ~14.0%, saving ~$1.7M in H2 2023 interest.
- Added up to $40M in additional borrowing capacity in four tranches through H1 2025, subject to revenue milestones.
- Principal payments deferred to Aug 2026 (or Aug 2027 if IP not pledged) vs previous Apr 2025; maturity extended to Jun 2028.
- Final payment fee of 5% of original principal; negative pledge on intellectual property.

## SEC filing metadata
- accession: 0000950170-23-031482
- form_type: 8-K
- ticker: RXST
- cik: 0001111485
- company_name: RxSight, Inc.
- filed_at: 2023-07-05T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1111485/000095017023031482/0000950170-23-031482-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1111485/000095017023031482/rxst-20230630.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-031482
- JSON: https://secwatch.observer/filing/0000950170-23-031482.json
- Plain text: https://secwatch.observer/filing/0000950170-23-031482.txt

## Key facts
- Debt Financings
  RxSight, Inc. incurred loan of $20.0 million in aggregate Term A Loans and up to $40.0 million in additional term loans available in four tranches with Oxford Finance, LLC as collateral agent and the lenders party thereto at floating per annum rate equal to the greater of 1-Month Term SOFR or 5.15% plus maturing June 1, 2028.
  - Instrument: loan
  - Principal: $20.0 million in aggregate Term A Loans and up to $40.0 million in additional term loans available in four tranches
  - Counterparty: Oxford Finance, LLC as collateral agent and the lenders party thereto
  - Rate: floating per annum rate equal to the greater of 1-Month Term SOFR or 5.15% plus
  - Maturity: June 1, 2028
  - Event: incurrence
  source text: On June 30, 2023, the Company entered into a new Loan and Security Agreement (“New LSA”) with Oxford as collateral agent and the lenders party thereto, pursuant to which the Company borrowed $20.0 million in aggregate Term A Loans (the “Term A Loans”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1111485/000095017023031482/0000950170-23-031482-index.htm
- Material Agreements
  RxSight, Inc. terminated Retired LSA with Oxford Finance, LLC (effective 2023-06-30).
  - Action: termination
  - Agreement: credit facility
  - Counterparty: Oxford Finance, LLC
  - Effective: 2023-06-30
  source text: On June 30, 2023, the Company prepaid the Retired Term Loan using a combination of cash, primarily comprised of cash raised under the ATM Facility during the quarter ended June 30, 2023, and the Term A Loans (defined below) of $20.0 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1111485/000095017023031482/0000950170-23-031482-index.htm
- Material Agreements
  RxSight, Inc. entered into New LSA with Oxford Finance, LLC valued at $20.0 million (effective 2023-06-30).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: Oxford Finance, LLC
  - Value: $20.0 million
  - Effective: 2023-06-30
  source text: On June 30, 2023, the Company entered into a new Loan and Security Agreement (“New LSA”) with Oxford as collateral agent and the lenders party thereto, pursuant to which the Company borrowed $20.0 million in aggregate Term A Loans (the “Term A Loans”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1111485/000095017023031482/0000950170-23-031482-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.